The vaccine formulations were adminis- trated by subcutaneous (sc) injection once in every two weeks, three times for OVAliposome mixtures (10 μg of OVA/mouse/ injection) or two times for PAliposome mixtures (5 μg of PA/ mouse/injection) and cOVAlposome mixtures (10 μg of cOVA/mouse/injection).